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ABSTRACT
Theaimof thisworkwas toevaluate the releaseprofileofvancomycinhydrochloride
(VC), aswell as the degradation, in vitro antistaphylococcal effect and cytotoxicity in
MG-63 osteoblast-like cells of gelatin–starch (GS) films added with different con-
centrations of microparticles of the bioactive glass 45S5 (m-BG). The biomaterials
were obtained through the gel-casting method. Four different composites were
prepared at four different weight percentages of m-BG: 0, 5, 10, and 15 %. Glu-
taraldehyde 0.25 wt% (GA) was used as the cross-linker. The composites were
characterized by scanning electron microscopy and the in vitro degradation of the
filmswas studied bymeasuring thewater uptake andweight loss. The drug release
kinetics was quantified spectrophotometrically. The inhibition zone test and the
plate count method were used to evaluate the antibacterial activity of the samples.
Three staphylococcus strains were evaluated: Staphylococcus aureus ATCC6538, S.
aureus ATCC29213, and Staphylococcus epidermidis ATCC12228. Cytotoxicity effects
were evaluated through theMTTassay.Theadditionofm-BGtoGSfilmsshowedno
effects on the amount of water uptake, but led to an increase in the weight loss over
time, even with m-BG content. The release rate of VC was also affected by the
increasing concentration ofm-BG in the composite films.However, the antibacterial
effects of the composites were not improved by this modulation. All composites
strongly inhibited staphylococcal cells with similar strength. On the other hand,
liquid extracts fromthe composites resulted in cytotoxic effects onMG-63osteoblast-
like cells due to the presence of GA, but not to the concentration of VC or m-BG.
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Introduction
The pharmacokinetics, pharmacodynamics, non-
specific toxicity, and efficacy of drugs may be con-
trolled by various drug delivery systems [1]. The
controlled and sustained delivery of a certain drug
ensures that an adequate concentration will reach the
target organ over a long period of time and will thus
be therapeutically efficient [2]. In wound healing and
tissue engineering, the modulation of the release of a
drug is of particular interest because one important
factor that interrupts the healing is the bacterial
burden in the wound [3, 4]. Staphylococcus aureus and
Staphylococcus epidermidis are important pathogens
involved in wound infection [4].
Several drug delivery systems based on biopoly-
mers have been studied to optimize drug release
profiles because of their many interesting features,
including good biocompatibility, biodegradability,
and good mechanical properties [5, 6]. Among
biopolymers, gelatin stands out strongly due to sev-
eral key advantages: it is biodegradable, biocompat-
ible, and nonimmunogenic, and has hemostatic
properties [7, 8]. In addition, gelatin can be an
exceptionally adaptable drug delivery carrier because
drug loading and releasing kinetics from gelatin
matrices can be independently tuned [8–12]. Never-
theless, due to its high brittleness and low intensity,
gelatin is often used after modification by different
methods such as grafting [15], crosslinking [13, 14],
and blending [16–18].
Starch-based polymers and composites have also
been proposed as drug delivery systems [20, 21] and
have great potential to be applied in the biomedical
field [19]. Biodegradable starch-based polymers pre-
sent good compatibility, proper mechanical proper-
ties, and their degradation products are non-toxic
[19]. Corn starch can be used together with gelatin as
reinforcement to the polymeric matrix [22] and for
the controlled release of drugs [23].
In the last years, some researchers have shown that
the combination of bioactive glasses (BGs) with
biopolymeric matrices allows modifications in the
release profile of antibiotics, in particular vancomycin
hydrochloride (VC) [24–26]. Unfortunately, many
often, the biological response or antimicrobial effects
have been overlooked. VC is used to treat infections
caused by Gram-positive bacteria such as methicillin-
resistant S. aureus (MRSA) [27].
The addition of BGs to a biopolymeric matrix can
lead to several interesting biological properties [28].
BGs are being increasingly considered in bone tissue
engineering, due to their ability to bind strongly to
the bone and promote bone growth after in vivo
implantation [29, 30]. In addition, BGs have a huge
potential for applications in wound healing and soft
tissue engineering [31]. In particular, 45S5 BG is a
promising material for applications in soft tissue
engineering. For example, it has been demonstrated
that microparticles of 45S5 BG possess angiogenic
effects [32–34], promote the expression of genes
related to wound healing [35], and accelerate the
recovery of skin wounds [36]. The aim of this work
was to study the influence of increasing concentra-
tions of 45S5 BG microparticles (m-BG) on the water
uptake capacity, degradation behavior, and release
profile of VC. We also investigated the in vitro
antistaphylococcal effect and potential in vitro cyto-
toxicity on MG-63 human osteosarcoma cells of




Micrometer particles of the melt-derived 45S5 BG
(composition in wt%: 45 % SiO2, 24.5 % Na2O, 24.5 %
CaO, and 6 % P2O5) of particle size in the 5–100 lm
range were used. Edible gelatin Royal and corn starch
were from Kraft Foods Argentina. VC was from
Laboratorios Fabra S.A. (Buenos Aires, Argentina).
Glutaraldehyde (GA) solution (50 % in water, 5.6 M)
was purchased from Merck SA Argentina. Fetal
bovine serum (FBS) was purchased from Natocor SA
(Córdoba, Argentina). Maximum recovery diluent
was prepared according to the following formula:
Peptone, 1 g (Britania SA, Buenos Aires, Argentina),
NaCl, 8 g (Reagents SA, Buenos Aires, Argentina),
and distilled water, 1 L. Simulated wound fluid
(SWF) was prepared by mixing maximum recovery
diluent with FBS in equal volumes.
Composite films
The composite films were obtained by preparing a
5 % gelatin solution in distilled water and heating it
at 80 C for 10 min, then a 1 % starch solution in
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distilled water and heating it to 85 C for 5 min, and
then homogenizing the solutions. The ratio between
gelatin and starch was 5:1. Glycerol was added at a
concentration of 20 % in relation to the total volume
of solution and used as plasticizer. Four concentra-
tions of m-BG particles were used to obtain films with
0, 5, 10, and 15 % of m-BG respect to the polymer
solution. Before the addition of m-BG, the micropar-
ticles were passivated in phosphate-buffered saline
(PBS) for 12 h to avoid the sudden release of a high
ion concentration from the BG. The solutions were
cooled to 30 C with constant stirring to incorporate
VC at a concentration of 1 mg mL-1. Alternatively,
composites without VC loading were also prepared
as controls. Then 20 mL of the respective mixes were
placed in 8.5-cm-diameter polystyrene petri dishes
and the moldings were dried at 4 C. After drying,
composites were cross-linked for 10 min in a GA
solution (0.25 wt%). This concentration was chosen
because it has been previously reported that 0.25 wt%
of GA allows obtaining a crosslinking degree of
approximately 85 % and preventing the release of
gelatin into the buffer solution [37]. Finally, the
composites were washed gently in distilled water
and then dried at room temperature (25 C) for 24 h.
Morphological characterization
Scanning electron microscopy (SEM) was used to
characterize surface of films. According to previous
work [26], the films were fixed with a 2.5 % GA 0.1 M
PBS solution overnight at 4 C. After that the mate-
rials were washed with distilled water, and then
dehydrated by means of a graded series of ethanol
solutions. The samples were examined using a JEOL
JSM 6480 LV, Japan microscope.
In vitro degradation study
Water uptake assay
The water uptake capacity was determined as
described previously in Rivadeneira et al. [26]. The
films were cut and weighed. The materials were
incubated in 15 mL of water at 37 C. At regular
intervals, samples were removed and the excess of
water at surface was withdrawn with a filter paper.
The weights of films were recorded until reaching
equilibrium swelling. The water uptake capacity of
the films was calculated according to the Eq. (1):
Water uptake %ð Þ






The degradation pattern was studied at 37 C in PBS
through the weight loss profile of composites. Circle-
shaped composites (10 mm in diameter) were
immersed in PBS for up to 28 days. After each period
of time, films were washed twice with distilled water
to remove possible material adsorbed on the surface,
and then dried at 37 C. The PBS solution was
replaced twice a week. Three samples were assessed
for each group. The weight loss (WL) was calculated
by means of Eq. (2), where W0 is the initial weight
and W1 is the weight after soaking in PBS at a given
time:
WL %ð Þ ¼ W0 W1ð Þ=W0½   100 ð2Þ
In vitro VC release
The in vitro VC release was quantified as previously
described in Rivadeneira et al. [26]. The composites
were cut in 5-mm-diameter discs (area = 0.2 cm2)
with a paper punch incubated in 1 mL of distilled
water at 37 C. At predetermined intervals, the VC
concentrations were determined by measuring the
absorbance at a wavelength (k) = 280 nm on a UV–
Vis Thermo Spectronic Helios Beta v.460 (Thermo
Electron Corporation, Massachusetts, USA). Three
samples in each condition were evaluated. The data
are expressed as mean ± SD.
Antimicrobial efficacy
Staphylococcus aureusATCC6538, S. aureus ATCC29213,
and S. epidermidis ATCC12228 were cultured in
Mueller–Hinton broth for 24 h at 37 C. Bacterial cell
suspensions were adjusted to 6–7 log cfu mL-1. Pre-
vious to antibacterial experiments, film discs were
sterilized under UV light for 20 min each side.
Antibacterial efficacy was evaluated through the fol-
lowing two methods.
Zone of inhibition assay
Film discs of 5-mm diameter were placed on
Mueller–Hinton agar plates which had been
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previously seeded with 100 lL of described bacte-
rial suspension. Then the plates were incubated at
37 C for 24 h. Finally, the diameters of the inhibi-
tion zones were measured in mm. All tests were
performed in triplicate and the means and SD were
determined.
Viable counts
Viable counts were determined in SWF. The com-
posite samples were incubated for 48 h at 37 C in
2 mL of cellular suspensions. Each staphylococcus
suspension in presence of SWF only was used as
controls. Samples were collected at 0, 24 and 48 h
and spread on agar plates containing Mueller–
Hinton. The viability of cells was quantified by
counting in. All tests were performed in triplicate.
The results are expressed as log10 cfu mL
-1 ±SD.
The antibacterial activity was determined as the
difference between the log number of bacteria in the
control and that in the test composites. The
antimicrobial activity was classified as low, mod-
erate, or high according to the criterion of Gallant-
Behn et al. [38].
MG-63 osteoblast-like cells
MG-63 osteoblast-like cells were cultured in DMEM
medium supplemented with 10 % FBS, 100 lg mL-1
streptomycin, and 100 U mL-1 penicillin at 37 C in
a 5 % CO2 atmosphere. Cells were seeded in a
75-cm2 flask, and after reaching 70–80 % of conflu-
ence, the cells were removed from the flask by
trypsinization. To determined total cell counts and
the number of viable cells, a Trypan blue stain was
performed using a Neubauer hemocytometer. For
the experiments, cells were grown in multiwell
plates. After cells reached the desired confluence,
the monolayers were washed with DMEM and then
incubated under the different conditions of each
experiment.
Composite liquid extracts
Before cell incubation, the films (0.20 cm2) were
sterilized by UV light for 20 min each side. After, the
film discs were immersed in 1 mL of DMEM for 48 h
at 37 C. Control samples were obtained by incubat-
ing under the same condition DMEM medium
without the composites.
MTT assay
MTT assay was carried out as previously [39]. Briefly,
2.5 9 104 cells per well were seeded in a 96-multiwell
dish and incubated overnight to allow adherence.
Afterwards, the cells were exposed to liquid extracts
for 48 h. After exposure, the medium was remove
and cells were incubated with 0.5 mg mL-1 MTT
under normal culture conditions for 3 h. Cells were
lysed in DMSO (100 lL per well), and the absorbance
was measured at 570 nm in a Microplate Reader
(7530, Cambridge Technology, Inc., Karlstad, Swe-
den). Cell viability is shown as the percentage of the
control value (assuming data obtained from
untreated cells as 100 %).
Statistical analysis
Data were statistically analyzed by one-way analysis
of variance, ANOVA (SPSS 15.0 statistical package
software). Tukey’s multiple comparison post-tests for
intergroup analysis and p values of\0.05 were con-
sidered to be statistically significant.
Results
Composite films
Figure 1 shows the surface morphologies of VC-loa-
ded composites studied by SEM. GS films showed a
dense, smooth, and uniform surface (Fig. 1a). The
presence of m-BG particles led to the formation of
irregular protrusions on the surfaces of the films (see
arrows). An increase of the roughness of the surface
with increasing concentration of m-BGs in the films
can be qualitative assessed by inspection of the SEM
micrographs (Fig. 1b–d).
The addition of VC to the films did not affect the
morphology of the films in comparison to non-re-
leasing composites (not shown). The coating was
approximately 65.08 ± 3.75 lm for GS-BG5 %,
82.1 ± 2.55 lm for GS-BG10 %, and 106.67 ± 5.77 lm
for GS-BG15 %.
In vitro degradation
The values of water uptake capacity for each com-
posite (in %) are shown in Fig. 2a. We found no sta-
tistically significant differences in the water
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absorption capacity of the composites. The water
uptake capacity of the films was of the order of
250–300 %. The swelling reached equilibrium after
15 min.
Figure 2b shows the weight loss of films containing
VC grown in PBS for 28 days. The results show that
the mass loss increased gradually over time. After a
week, the weight loss of the composites was similar.
Nevertheless, after this time, the GS-BG films showed
faster degradation than the GS films. GS-10 % BG and
GS-15 % BG were completely degraded by day 20.
On the other hand, after 28 days of degradation, GS
had a maximum mass loss of 43 % and GS-5 % BG a
maximum mass loss of 57 %. However, the difference
was not statistically significant.
Effects of 45S5 m-BG on VC release
Figure 3 shows the release behavior of VC from the
films. A burst release was expected during the first
hours due to the hydrophilic nature of VC. In general,
the release profiles followed typical three phases: a
rapid release phase during the first hours; a decrease in
the release rate and a change in the slope of the curves;
and a zero order release (constant release rate), which
lasted until the end of the experiment. The release rate
of VC from the composites was modified by the
presence of 45S5 m-BG. The amount of VC released to
the medium increased as the m-BG concentration
increased. Most of the VC was released during the first
24 h. At this time, the amount of VC released was
0.147 ± 0.080 mg mL-1 for GS, 0.2078 ± 0.087 mg
mL-1 for GSBG-5%, 0.2526 ± 0.060 mg mL-1 for
GSBG-10%, and 0.2867 ± 0.020 mg mL-1 for GSBG-
10%.
In the first stage, GS-BG films showed an abrupt
initial burst release, while GS films showed a much
lower initial release of VC. In the second stage, GS
films exhibited a longer release period than GS-BG
composites and showed a controlled release of VC.
Antibacterial effects
Inhibition zone
The values of the inhibition zone (in mm) around the
composites are shown in Table 1. The presence of the
composites inhibited the growth of the three
staphylococcus strains tested. S. aureus ATCC6538
showed the largest inhibition zone, whereas S. aureus
ATCC29213 and S. epidermidis ATCC12228 showed
inhibition zones of similar size. The addition of 45S5
Figure 1 SEM images of films. GS films (a), GS-BG5 % (b), GS-BG10 % (c), GS-BG15 % (d).
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m-BG to the composites showed no effects on the
efficacy of bacterial inhibition. Films not releasing VC
developed no inhibition zones.
Viable counts
The initial cell concentrations (expressed as log10
cfu mL-1) were 5.52 ± 0.27 for S. aureus ATCC6538,
5.66 ± 0.28 for S. aureus ATCC29213, and 5.79 ± 0.14
for S. epidermidis ATCC1228 (Fig. 4). No statistical
differences were observed in the initial inoculum size
between the strains. The composites strongly inhib-
ited the cell viability of the Staphylococcus spp.
tested, with similar strength. After 24 h, cell viability
was around 4.30 log10 cfu mL
-1 for S. aureus
ATCC6538, 4.33 log10 cfu mL
-1 for S. aureus
ATCC29213, and 4.50 log10 cfu mL
-1 for S. epider-
midis. After 48 h, the cell viability of the three strains
was below the detection limits. In terms of antimi-
crobial activity, the composites presented high
antimicrobial activity at 48 h, since growth inhibi-
tions were higher than 3-log reduction.
Cell cytotoxicity
Figure 5 exhibits the viability of MG-63 cells which
had been cultured for 24 h in the presence of the
composites. The control group consisted of MG-63
cells cultured without addition of composites. Cells
incubated in the presence of the composites with or
without VC were significantly inhibited. The cyto-
toxicity was related to the presence of GA and not to
Figure 2 In vitro degradation study. Water uptake capacity of
films along the incubation time (a); weight loss of films incubated
in PBS at 37 C for the time period indicated (b). Results are
reported as mean ± SD. Asterisk indicates p\ 0.05.
Figure 3 Vancomycin hydrochloride release profile from films as
a function of time. The data are expressed as the mean ± SD.
Table 1 Inhibition zone around composites N = 3 (mm)
Staphylococcus strain
Composites ATCC6538 ATCC29213 ATCC12228
GS 21 ± 2.83 17.5 ± 1.75 18 ± 1.41
GS-BG5% 17.5 ± 0.71 17 ± 2.12 15.25 ± 2.47
GS-BG10% 18 ± 1.41 15 ± 0.71 17 ± 2.43
GS-BG15% 19.75 ± 1.77 14 ± 1.04 15.5 ± 2.12
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the concentration of m-BG or the presence of VC. This
result follows from the fact that there were no sig-
nificant differences between GS films and GS plus
m-BG films. In addition, composites with VC and
without VC exhibited similar cytotoxicity.
Discussion
Several researchers agree that BG systems including
45S5 composition can modify the release profile of a
drug [24–26]. Unfortunately, the biological conse-
quences of this effect have been often overlooked.
Here, for the first time, we studied the release profile
of a drug (VC), and the water uptake capacity,
degradation, in vitro antistaphylococcal effect, and
cytotoxicity (on MG-63 osteoblast-like cells) of GS
films with increasing concentration of 45S5 m-BG.
When chemical cross-linked biopolymer films are
developed for drug delivery applications, a very
important parameter should be considered is the
water uptake capacity. This parameter will affect not
only the film morphology and structure [40] but also
the drug release rate in diffusion-controlled systems
[41].
In the present study, the water uptake capacity of
the polymer was not affected by the presence of
bFigure 4 Viable counts of Staphylococcus aureus ATCC6538
(a), S. aureus ATCC29213 (b), and S. epidermidis ATCC1228
(c) in the presence of films. Asterisk indicates a statistically
significant difference at p\ 0.05 between VC-releasing films and
control cell suspensions at time 0.
Figure 5 Cell survival percentage of the human osteosarcoma
cell line MG63 in the presence of VC-releasing and non-releasing
films. Asterisk indicates a statistically significant difference at
p\ 0.05 between VC-releasing films and control groups.
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m-BG in the polymeric matrix. Although this is in
accordance with our previous results [26] and with
results of other authors [42], other studies have
reported opposite findings [43–45]. These discrepan-
cies can be explained by the nature of the biopoly-
meric matrix or the BG particle size. More
specifically, when 45S5 m-BG nanoparticles are
included in hydrophobic polymers, the water uptake
capacity is improved [43, 44]. On the other hand, 45S5
BG nanoparticles seem to enhance the water uptake
capacity, probably due to the higher time of exposure
and larger surface area [45].
Another parameter that should be considered is
the degradation behavior of biomaterials in a phys-
iological environment, since this parameter plays an
important role in the regeneration of new cells [46].
After implantation, biomaterials interact with the
fluids of the tissue and a degradation process starts.
The in vitro degradation rate of composite materials
is determined as a function of the hydrolysis time in
PBS in normal physiological conditions (pH 7.4 at
37 C). The weight loss increases over the incubation
period and with the increasing concentrations of
45S5 m-BG [44, 47, 48]. Nevertheless, some studies
have shown that the addition of BGs reduces the
degradation rate of biomaterials [49–52]. The pro-
posed explanations for the slower degradation lies
on that the BG particles induce a rapid exchange of
protons in the water for the alkali in the BG, pro-
viding a pH buffering effect that neutralizes the
acidic degradation of the by-products produced
during hydrolysis, thus preventing the autocatalytic
effect [43, 44]. Another possible effect is that the
degradation rate decreases because the incorporation
of inorganic filler into the polymer matrix decreases
the porosity of composites [51]. A decrease in
porosity leads to a decrease in the surface area
exposed to the medium [52]. In this study, the
presence of BG particles could have increased the
surface area of the composites and could have
accelerated the degradation of GS-BG samples.
Indeed, as mentioned in the materials and methods
section, 45S5 m-BG samples were previously incu-
bated in PBS before being added to the polymeric
matrix to eliminate the increase in pH that could
induce cell damage or that could degrade the
antibiotic [53]. In that way, the aforementioned pH
buffering effect is likely not taking place in the pre-
sent composites. Finally, it has been proposed that
the increased weight loss in the presence of BG could
be related to the dissolution of the BG particles, as
previously reported for other composites [47, 54, 55].
Contextualizing these results for a potential appli-
cation of the composites in wound dressing engi-
neering, some considerations can be made. In wound
dressing engineering, the choice of a polymer or
polymer combination depends on the fact that
degradation rate matches the typical wound healing
time frame for proper tissue influx. Many factors
affect wound healing but, in normal conditions for
skin wounds, the expected healing time frame is
about 4 weeks [56]. Here, we found that, in general,
films containing 45S5 m-BG degraded too fast in
relation with the wound healing time frame. Never-
theless, the degradation of biomaterials can be mod-
ulated and improved by different techniques like
blending [57], incorporation of enzymatic inhibitors
[58], or crosslinking [59].
The drug release rate of VC was found to be
affected by the presence of m-BG. This modulation
depended, in general, on the m-BG concentration.
This result is in agreement with previous research
data [52, 60]. A possible explanation for this behavior
arises from chemical and physical considerations.
Chemically, the drug and the biopolymeric matrix
may have a greater bounding affinity [52]. Physically,
BG particles in the polymeric matrix leave no free
space for the antibiotic, promoting the fast release of
the drug [52, 61]. This can also be explained by the
increase in the surface area of the composite by the
addition of m-BG, as previously discussed [62].
Both the water uptake capacity and the degrada-
tion rate also play important roles in the release
kinetics of a drug [60]. If water uptake is higher, the
matrix would be more openly spaced and thus easier
for drugs to diffuse out. Material degradation also
offers relatively large open channels, thus accelerat-
ing drug diffusion [60]. Since the addition of m-BG
accelerates the degradation of composite films, this
effect could explain the results found here.
The treatment of the agar plates with drug-loaded
composite films led to obvious inhibition zones. The
inhibition zones were not affected by the m-BG con-
centration. On the other hand, there were no inhibi-
tion zones in films not releasing VC, which indicates
the lack of bactericidal activity in the absence of the
antibiotic. This result is relevant since previous
research has reported antibacterial effects of 45S5 BG
per se [63–66]. Here, the antibacterial effects depen-
ded on the release of VC. The plate count method
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showed that the composites strongly inhibited the
growth of staphylococcal cells in SWF. The exposure
of the three staphylococcal strains tested to compos-
ites after 48 h resulted in a reduction of the total
viable count. Interestingly, the composite exhibited
similar antibacterial strength. This means that the
greater concentration of VC released by the GS-BG
composites (Fig. 3) does not indicate an improvement
in their antibacterial effects. This phenomenon, where
the drug concentration is not related to the antibac-
terial strength, is in agreement with our previous
results [26, 39] and with those of other authors with
related biomaterials [67].
In the context of wound regeneration, the release of
a drug to a wound depends on the condition of the
wound [68]. Often, a burst release is considered as a
negative consequence of long-term controlled release
systems [69]. Nevertheless, high initial delivery rates
or rapid release may sometimes be desirable [69] and
should be considered in the immediate performance
of dressings [68]. A high burst release followed by a
decreased release over several days may allow a
robust response and eliminate large numbers of
bacteria, and can therefore be suitable in cases of
developing infection. In a wound, it is commonly
accepted that a concentration of bacteria above 105
cfu mL-1 determines an infection [70, 71]. In this
context, the presence of m-BG on films led to an
abrupt initial burst of VC release, which is suitable to
control the large number of bacteria present in
infected wounds.
To complete the results of bacterial inhibition, the
composites should be non-toxic to mammalian cells.
Biomaterials may be toxic to cells due to the dressing
material itself, the material processing or the incor-
poration of antimicrobials [68]. Here, the results
obtained by the MTT assay (Fig. 5) showed that the
composites exerted some cytotoxicity. Nevertheless,
this cytotoxicity was related to the presence of GA
but not to the concentration of m-BG or to the amount
of VC released to the medium. This finding supports
the idea of BGs as promising materials for soft tissue
engineering and wound healing [31], since the pres-
ence of BGs can impart superior functionalities to a
biopolymeric film than the biopolymeric matrix by
itself.
As mentioned above, some of the limitations of
biomaterials, such as the lack of adequate mechanical
properties, can be overcome by crosslinking [59].
According to other authors, the cytotoxicity of GA
depends on the concentration used, and up to 8 %
GA has been found to be non-cytotoxic [72]. In this
work, 0.25 % GA resulted in cytotoxicity to human
osteoblast-like cells. Nevertheless, this kind of limi-
tation can be overcome using other crosslinking
agents like genipin, which has been demonstrated to
be much less cytotoxic [71, 73].
Conclusions
The present research demonstrated that the presence
of 45S5 m-BG in gelatin–starch films can modulate a
number of physicochemical parameters of relevance
in drug delivery system engineering. In particular,
the degradation and VC release rates can be affected
by increasing concentrations of 45S5 m-BG, but the
water uptake capacity of GS films does not depend
on the BG content. These modifications did not lead
to changes in the antibacterial effects of the compos-
ites or to cytotoxicity effects. Future research should
focus on finding a proper cross-linker agent for
gelatin and investigating the biological response of
composites in relation to wound healing.
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